Table 1.
Characteristics of Young Adult Cancer Patients Diagnosed During 2007–2012 by Age Group, SEER Program
| Characteristics | Patients | |||
|---|---|---|---|---|
| Total % (n) |
Aged 18–25 Years % |
Aged 26–29 Years % |
p-value* | |
| No. of Patients | 39,632 | 21,299 | 18,333 | |
| Any Health Insurance | ||||
| Yes | 83.8% (33,195) | 84.2% | 83.2% | <0.01 |
| No | 16.2% (6,437) | 15.8% | 16.8% | |
| Medicaid Health Insurance | ||||
| Yes | 17.7% (7,013) | 18.5% | 16.8% | <0.01 |
| No | 82.3% (32,619) | 81.5% | 83.2% | |
| Time period | ||||
| Pre-ACA (2007–Sept. 2010) | 62.0% (21,299) | 37.9% | 38.2% | 0.45 |
| Post-ACA (Oct. 2010–2012) | 38.0% (15,069) | 62.2% | 61.8% | |
| Gender | ||||
| Female | 55.4% (21,963) | 52.5% | 58.8% | <0.01 |
| Male | 44.6% (17,669) | 47.5% | 41.2% | |
| Race/Ethnicity | ||||
| Non-Hispanic White | 58.9% (23,359) | 58.5% | 59.5% | <0.01 |
| Non-Hispanic Black | 9.1% (3,622) | 9.1% | 9.2% | |
| Hispanic | 21.6% (8,553) | 22.3% | 20.8% | |
| Non-Hispanic Other/Unknown | 10.3% (4,094) | 10.2% | 10.2% | |
| Marital Status | ||||
| Married | 23.9% (9,466) | 12.9% | 36.6% | <0.01 |
| Not Married | 76.1% (30,166) | 87.1% | 63.4% | |
| Cancer Registry | ||||
| Alaska | 0.2% (59) | 0.2% | 0.1% | <0.01 |
| California | 41.7% (16,542) | 42.9% | 40.4% | |
| Connecticut | 3.9% (1,560) | 4.1% | 3.7% | |
| Georgia | 10.4% (4,126) | 10.1% | 10.8% | |
| Hawaii | 1.7% (689) | 1.7% | 1.8% | |
| Iowa | 3.8% (1,515) | 3.8% | 3.9% | |
| Kentucky | 5.2% (2,051) | 4.6% | 5.9% | |
| Louisiana | 5.1% (2,011) | 4.9% | 5.3% | |
| Michigan | 4.4% (1,754) | 4.6% | 4.3% | |
| New Jersey | 10.4% (4,137) | 10.8% | 10.0% | |
| New Mexico | 2.3% (899) | 2.3% | 2.2% | |
| Utah | 4.4% (1,725) | 4.1% | 4.6% | |
| Washington | 6.5% (2,564) | 6.1% | 7.0% | |
| Cancer Site/ Type | ||||
| Leukemias | 5.9% (2,318) | 7.1% | 4.4% | <0.01 |
| Lymphomas | 15.0% (5,953) | 17.8% | 11.8% | |
| CNS/other intracranial/spinal neoplasms | 5.0% (1,984) | 5.6% | 4.3% | |
| Osseous/chondromatous neoplasms | 2.1% (814) | 2.8% | 1.1% | |
| Soft tissue Sarcomas | 4.5% (1,788) | 4.8% | 4.2% | |
| Germ cell/trophoblastic neoplasms | 14.4% (5,687) | 15.8% | 12.7% | |
| Melanoma/skin carcinomas | 9.7% (3,834) | 8.8% | 10.7% | |
| Other carcinomas | 33.3% (13,194) | 27.4% | 40.2% | |
| Unclassified neoplasms | 10.2% (4,060) | 9.8% | 10.7% | |
| Stage at Diagnosis | ||||
| In Situ | 7.3% (2,887) | 6.8% | 7.9% | <0.01 |
| Localized | 35.7% (14,717) | 33.4% | 41.5% | |
| Regional | 16.0% (6,324) | 15.3% | 16.8% | |
| Distant | 13.4% (5,327) | 14.7% | 11.9% | |
| Unstaged/Unknown | 26.2% (10,377) | 29.8% | 22.0% | |
Notes:
Percentages may not add to 100 due to rounding.
SEER=Surveillance, Epidemiology, and End Results Program
ACA=Patient Protection and Affordable Care Act
CNS=Central Nervous System
% (n)=Percent (Number of Patients)
*
p-values were computed for 18–25 vs. 26–29 year olds using Chi-squared tests